In short.
Retatrutide (LY3437943) is a synthetic research peptide characterised in the literature as a triple agonist of the GLP-1, GIP and glucagon receptors. BuyRetaUK supplies it as a lyophilised powder at ≥99% HPLC purity, with a batch-specific Certificate of Analysis, for in-vitro laboratory research use only — not for human or veterinary use.
At a glance.
Overview.
Retatrutide is a synthetic research peptide of interest to laboratories studying the incretin system. Detailed editorial copy is being prepared for this section by our scientific writing team.
Mechanism of action.
In published literature, retatrutide has been characterised as an agonist at three receptors — GLP-1, GIP and glucagon. Detailed mechanism content is in preparation.
Research applications.
Retatrutide is studied as a tool compound across metabolic, energy-balance and body-composition research models. Expanded section content is being prepared.
Laboratory quality.
Every BuyRetaUK batch is produced to research-grade specifications, stored under temperature control in our UK facility and shipped with full batch traceability.
Purity & testing.
Identity and purity are confirmed by independent third-party analysis using reverse-phase HPLC and mass spectrometry. Our release specification is ≥99% HPLC purity.
Storage & handling.
Lyophilised vials are stored at 2–8°C, protected from light. After reconstitution with bacteriostatic water, store refrigerated and use within approximately 30 days.
Compare retatrutide.
Triple agonist vs dual agonist — receptor profile, class and research framing.
Read →Triple receptor agonist vs single GLP-1 agonist in laboratory research.
Read →Why simultaneous GLP-1 / GIP / glucagon activity matters in research.
Read →FAQs.
What is retatrutide?[+]
Retatrutide (LY3437943) is a synthetic research peptide characterised as a triple agonist of the GLP-1, GIP and glucagon receptors. It is supplied as a lyophilised powder for in-vitro laboratory research only.
Is retatrutide approved for human use?[+]
No. Retatrutide is supplied strictly for laboratory research and is not approved for human or veterinary administration.
What receptors does retatrutide act on?[+]
Retatrutide is characterised in the literature as acting on the GLP-1, GIP and glucagon receptors simultaneously — a triple agonist profile.
What purity is BuyRetaUK retatrutide?[+]
Our retatrutide is released at ≥99% HPLC purity, with identity confirmed by mass spectrometry. Every vial ships with a batch-specific Certificate of Analysis.
How should retatrutide be stored?[+]
Store lyophilised vials at 2–8°C, protected from light. Once reconstituted with bacteriostatic water, store refrigerated and use within approximately 30 days.
How does retatrutide compare to tirzepatide and semaglutide?[+]
Retatrutide is a triple agonist (GLP-1 / GIP / glucagon). Tirzepatide is a dual agonist (GLP-1 / GIP). Semaglutide is a single GLP-1 agonist. See our comparison guides for full side-by-side analysis.
Further reading & sources.
- BuyRetaUK Retatrutide product page
- BuyRetaUK Retatrutide collection
- Certificate of Analysis library
- Knowledge Hub
Peer-reviewed citations are added as this cornerstone guide is expanded.
Related research peptides.
Continue reading.
Background on retatrutide in the academic literature — receptor pharmacology, study context and analytical handling.
8 min read →Product ComparisonsSide-by-side comparison of retatrutide and tirzepatide across receptor profile, research context and analytical considerations.
5 min read →Certificates of AnalysisHow to read a peptide certificate of analysis — identity, purity, mass and endotoxin sections explained.
7 min read →Storage & HandlingHow to store lyophilised research peptides and reconstitute them correctly for laboratory use.
4 min read →